(Q37978220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Oncologic applications of diffusion-weighted MRI in the body (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

magnetic resonance imaging

21 January 2020

main subject

0 references

author

Susanne Bonekamp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Susanne Bonekamp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Celia P Corona-Villalobos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ihab R Kamel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

1 reference

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

Journal of Magnetic Resonance Imaging

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

257-279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Spin Diffusion Measurements: Spin Echoes in the Presence of a Time-Dependent Field Gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Basic concepts of MR imaging, diffusion MR imaging, and diffusion tensor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted imaging: basic concepts and application in cerebral stroke and head trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Basic concepts of advanced MRI techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Can a single-shot black-blood T2-weighted spin-echo echo-planar imaging sequence with sensitivity encoding replace the respiratory-triggered turbo spin-echo sequence for the liver? An optimization and feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Single breath-hold diffusion-weighted MRI of the liver with parallel imaging: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

The value of diffusion-weighted imaging in characterizing focal liver masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: impact of parallel imaging (SENSE) and b value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted MR imaging of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging in the upper abdomen: technical issues and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: preliminary study and results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

ADC measurement of abdominal organs and lesions using parallel imaging technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion Coefficients in Abdominal Organs and Hepatic Lesions: Evaluation with Intravoxel Incoherent Motion Echo-planar MR Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Pediatric littoral cell angioma of the spleen: multimodality imaging including diffusion-weighted imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Measuring anisotropic diffusion in kidney using MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Usefulness of diffusion-weighted imaging in the evaluation of renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Free-breathing diffusion-weighted single-shot echo-planar MR imaging using parallel imaging (GRAPPA 2) and high b value for the detection of primary rectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion MRI for prediction of response of rectal cancer to chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

ADC mapping of benign and malignant breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion imaging of human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Advances in breast MRI: diffusion-weighted imaging of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Accuracy of diffusion-weighted MR imaging for differentiation of pulmonary lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Percutaneous radiofrequency ablation of lung tumors: evaluation of the literature using evidence-based techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Endovaginal magnetic resonance imaging of stage 1A/1B cervical cancer with A T2- and diffusion-weighted magnetic resonance technique: effect of lesion size and previous cone biopsy on tumor detectability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

The influence of the b‐value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Discrimination of metastatic from hyperplastic pelvic lymph nodes in patients with cervical cancer by diffusion-weighted magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Node-by-node correlation between MR and PET/CT in patients with uterine cervical cancer: diffusion-weighted imaging versus size-based criteria on T2WI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted Imaging of Peritoneal Disease for Noninvasive Staging of Advanced Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Prostate Cancer: Differentiation of Central Gland Cancer from Benign Prostatic Hyperplasia by Using Diffusion-weighted and Dynamic Contrast-enhanced MR Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Changes in diffusion-weighted images for visualizing prostate cancer during antiandrogen therapy: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted and macromolecular contrast enhanced MRI of tumor response to antivascular therapy with ZD6126.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Whole-body diffusion-weighted imaging for staging malignant lymphoma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Quantitative diffusion imaging in breast cancer: A clinical prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-weighted MRI in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Magnetic resonance diffusion imaging of ovarian masses: a first experience with 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

MR microimaging of benign and malignant nodes in the neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Diffusion-Weighted MRI of Peripheral Zone Prostate Cancer: Comparison of Tumor Apparent Diffusion Coefficient With Gleason Score and Percentage of Tumor on Core Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

Contribution of Diffusion-Weighted Imaging to Dynamic Contrast-Enhanced MRI in the Characterization of Breast Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22786

21 January 2018

Identifiers

DOI

10.1002/JMRI.22786

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22271274%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference